q4
play

Q4 2019 January - December Strong fourth quarter as expected, - PowerPoint PPT Presentation

FINANCIAL STATEMENT Q4 2019 January - December Strong fourth quarter as expected, stable development throughout the year PETTERI JOKITALO, CEO, SCANFIL PLC Q4 DRIVERS AND MARKET DEVELOPMENT Highlights Strongest quarter in terms of


  1. FINANCIAL STATEMENT Q4 2019 January - December Strong fourth quarter as expected, stable development throughout the year PETTERI JOKITALO, CEO, SCANFIL PLC

  2. Q4 DRIVERS AND MARKET DEVELOPMENT Highlights • Strongest quarter in terms of sales, + 15 M€ / +10% Q4 2019 • 2/3 of the growth from HASEC 154.7 M€ • Strong growth particularly in Industrial & Medtec Turnover segment +10.3% • Profitability according to expectations 6.5%, growth from Increase in turnover last year +33% 10.0 M€ / 6.5% Operating profit + 33.2% increase 9.8 M€ Net profit 0.15 € Earnings per share 2

  3. Q1 - Q4 DRIVERS AND MARKET DEVELOPMENT Highlights • Stable development, 579.4 M€, turnover grew +2.9% Q1 - Q4 2019 • Growth challenging in H1, H2 growth continued 579.4 M€ • HASEC aquisition, strategic importance Turnover • The Board of Directors proposes a dividend of EUR +2.9% 0.15 (0.13) per share to be paid for year 2019 Increase in turnover • 39.4 M€ / 6.8% Dividend proposal, dividend has raised for 7 Adjusted operating profit* consecutive years 35.3 M€/ 6.1% *The adjustment items during January-December include expenses related to the acquisition of Scanfil Electronics GmbH (former name HASEC-Elektronik GmbH) (EUR 0.4 million) and the impairment of Scanfil GmbH’s goodwill Operating profit (EUR 3.6 million) 28.1 M€ Net profit 0.44 € Earnings per share 0.50 € Adjusted earnings per share 3

  4. Customer Segments % of turnover Q4/2018 2018 Q1/2019 Q2 /2019 Q3/2019 Q4/2019 2019 2019 EUR million Communication 27.2 97.5 17.9 19.4 21.4 20.7 79.4 13.7 % Consumer Applications 25.1 125.6 23.5 27.6 27.8 28.3 107.3 18.5 % Energy & Automation 27.7 107.5 25.7 28.3 27.9 29.4 111.3 19.2 % Industrial 35.1 134.6 35.9 41.5 49.0 46.8 173.3 29.9 % Medtec & Life Science 25.2 97.9 26.9 25.7 26.1 29.4 108.1 18.7 % 579.4 100.0 % Total 140.2 563.0 129.9 142.6 152.3 154.7 4

  5. 2016 - 2019 Operating Profit 7.9 12,0 8 7.4 7.4 7.2 7 6.5 6.5 6.7 10,0 6,6 6.2 6 5.4 8,0 5.3 5.3 5.0 5 EUR million 4.1 6,0 4 % 3.9 3.5 3 4,0 2 2,0 1 0,0 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 2016 2017 2018 2019 Liikevoitto, oikaistu (EUR million) Liikevoitto, % oikaistu Operating profit adjusted (EUR million) Operating profit % adjusted 5

  6. Key Figures Q4/2019 Q4/2018 Change% 2019 2018 Change % Turnover, EUR million 154.7 140.2 10.3% 579.4 563.0 2.9% Operating Profit, EUR million 10.0 7.5 33.2% 35.3 37.8 -6.4% Operating Profit, Adjusted, EUR million 10.0 7.5 33.2% 39.4 37.8 4.2% Operating Profit, % 6.5 5.4 6.1 6.7 Operating Profit, Adjusted, % 6.5 5.4 6.8 6.7 Net Profit, EUR million 9.8 6.4 52.2% 28.1 28.9 -2.7% Net Profit, Adjusted, EUR million 9.8 6.4 52.2% 32.1 28.9 11.1% Earnings per Share, EUR 0.15 0.10 50.0% 0.44 0.45 -3.3% Earnings per Share, Adjusted, EUR 0.15 0.10 50.0% 0.50 0.45 10.5% Return on Equity, % 18.0 21.5 Return on Equity, Adjusted, % 20.4 21.5 Equity Ratio, % 49.1 47.7 Net Gearing, % 27.7 19.5 Net Cash Flow from Operations, EUR million 35.9 29.0 23.4% Employees (Average) 3 530 3 414 3.4% 6

  7. 2012 - 2019 Turnover M€ CAGR 579 600 563 18% 530 550 508 500 450 377 400 350 300 250 215 189 181 200 150 100 50 0 2012 2013 2014 2015 2016 2017 2018 2019 7

  8. 2012 - 2019 Operating Profit % M€ 39.4 CAGR 40 12 37.8 25% 35 10 31.3 30 8 7.6% 6.8% 25 6.7% 22.3 6.3% 5.9% 19.6 20 6 16.2 4.5% 5.2% 15 11.8 4 4.4% 10 8.1 2 5 0 0 2015 2013 2014 2012 2016 2017 2018 2019 Operating Profit Operating Profit adjusted 8

  9. 2012 - 2019 Cash Flow from Operations M€ 40 35.9 EUR 3.2 35 million impact from IFRS 16 30 25 20 15 29.0 21.3 10 16.5 13.2 13.0 11.2 11.0 5 0 2014 2015 2016 2017 2018 2019 2012 2013 9

  10. 2012 - 2019 Strong Financials Net Debt 70 65,6 60 50 46,2 40,7 40 Lease liability 40 2019 EUR 22.3 EUR million million 28,2 30 20 10 0 -1,8 -10 -9,8 -9,9 -20 2017 2018 2019 2012 2013 2015 2016 2014 Net debt 10

  11. 2012 – 2019 Strong Financials Gearing % 70 60 50 40 65.4 30 27.7 Gearing without 20 IFRS 16 impact 36.9 32.6 16.1% 10 19.5 0 -2,4 -10.5 -12.2 -10 -20 2012 2013 2016 2014 2015 2017 2018 2019 11

  12. 2012 - 2019 ROE and ROI ROE ROI 22.2% 21.5% 20.2% 19.4% 20.4% 16.5% 17.0% 18.0% 13.8% 13.6% 14.0% 11.4% 10.6% 10.6% 8.1% 7.9% 8.6% 4.6% 0.1% 2012 2013 2014 2015 2016 2017 2018 2019 2012 2013 2014 2015 2016 2017 2018 2019 ROE ROE, adjusted ROI 12

  13. 2012 - 2019 EPS 0,60 0.50 0,50 0,40 CAGR 26% 0,30 0.25 0.24 0.45 0,20 0.40 0.21 0,10 0.14 0.10 0,00 2012 2014 2015 2016 2017 2018 2019 2013 EPS EPS adjusted 13

  14. 2012 - 2019 Growing Dividend and Pay-Out Ratio Dividend per share 0.15 CAGR 21% € 0.13 0.11 0.09 0.08 0.07 0.05 0.04 2014 2019 proposal 2015 2012 2013 2016 2017 2018 Pay-Out 40.5 35.1 32.9 55.2 27.2 28,9 34.3 N/A Ratio % 14

  15. 2020 Outlook Scanfil estimates that its turnover for 2020 will be EUR 590 – 640 million and adjusted operating profit will amount to EUR 39 – 43 million. The estimation is based on our existing understanding of impact of Coronavirus. The 2020 guidance is subject to exceptional uncertainty due to the potential negative impact of the Coronavirus epidemic on customer demand and, in particular, the situation in China. 15

  16. Long term target Scanfil has updated its long-term target: In 2023, Scanfil is organically aiming for EUR 700 million turnover and 7% operating profit. In addition, Scanfil is actively exploring acquisitions, especially in the Nordic countries and Central Europe. 16

  17. Time for questions 17

  18. Contact information Inderes Oy Antti Viljakainen +358 44 591 2216 and analysts antti.viljakainen(at)inderes.fi Evli Pankki Oyj Joonas Ilvonen +358 44 430 9071 joonas.ilvonen(at)evli.com OP Yrityspankki Oyj Kimmo Stenvall PETTERI JOKITALO, CEO +358 10 252 4561 +358 44 7882400 kimmo.stenvall(at)op.fi petteri.jokitalo@scanfil.com Nordea Oyj MINNA OKSANEN, Communications Director Pasi Väisänen +358 44 7882409 +358 9 5300 5192 minna.oksanen@scanfil.com pasi.vaisanen(at)nordea.com

  19. Disclaimer Not to be published or distributed, directly or indirectly, in any country where its distribution or publication is unlawful. Forward looking statements: certain statements in this presentation may constitute "forward-looking" statements which involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements of Scanfil Oyj to be materially different from any future results, performance or achievements expressed or implied by such forward- looking statements. When used in this presentation, such statements use such words as "may," "will," "expect," "anticipate," "project," "believe," "plan" and other similar terminology. New risk factors may arise from time to time and it is not possible for management to predict all of those risk factors or the extent to which any factor or combination of factors may cause actual results, performance and achievements of Scanfil Oyj to be materially different from those contained in forward-looking statements. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual results. The forward-looking information contained in this presentation is current only as of the date of this presentation. There should not be an expectation that such information will in all circumstances be updated, supplemented or revised, except as provided by the law or obligatory regulations, whether as a result of new information, changing circumstances, future events or otherwise. 19

  20. Global contract manufacturer and systems supplier

Recommend


More recommend